Therapies for Alzheimer's disease.
Melnikova
Irena
I
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000523:psychology; D023582:Alzheimer Vaccines / Q000627:therapeutic use; D053829:Amyloid Precursor Protein Secretases / Q000037:antagonists & inhibitors; D016229:Amyloid beta-Peptides / Q000037:antagonists & inhibitors / Q000276:immunology; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use; D018755:GABA Agonists / Q000627:therapeutic use; D006801:Humans; D007114:Immunization; D008559:Memantine / Q000627:therapeutic use; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors; D013654:Taurine / Q000031:analogs & derivatives / Q000627:therapeutic use
D023582:Alzheimer Vaccines; D016229:Amyloid beta-Peptides; D002800:Cholinesterase Inhibitors; D018691:Excitatory Amino Acid Antagonists; D018755:GABA Agonists; D016194:Receptors, N-Methyl-D-Aspartate; D013654:Taurine; C001355:tramiprosate; D053829:Amyloid Precursor Protein Secretases; D008559:Memantine